{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:04:18Z","timestamp":1790345058358,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006304","name":"Aalborg University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","award":["DNRF148"],"award-info":[{"award-number":["DNRF148"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ero.2026.100198","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:52:25Z","timestamp":1780001545000},"page":"100198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of diabetes mellitus on mortality in patients with giant cell arteritis"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5590-1305","authenticated-orcid":false,"given":"Mads Engell Refstrup","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5984-5134","authenticated-orcid":false,"given":"Kirsten","family":"Duch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4047-7175","authenticated-orcid":false,"given":"Line","family":"Uhrenholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5156-2922","authenticated-orcid":false,"given":"Lene Wohlfahrt","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4578-1328","authenticated-orcid":false,"given":"Johan","family":"R\u00f8ikjer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Ejskjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5759-7942","authenticated-orcid":false,"given":"Bolette Gylden","family":"Soussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-5234","authenticated-orcid":false,"given":"Salome","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ero.2026.100198_bib0001","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ero.2026.100198_bib0002","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40264-015-0339-z","article-title":"Drug-induced hyperglycaemia and diabetes","volume":"38","author":"Fathallah","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.ero.2026.100198_bib0003","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrrheum.2012.97","article-title":"Clinical features of polymyalgia rheumatica and giant cell arteritis","volume":"8","author":"Salvarani","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ero.2026.100198_bib0004","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/acr.23901","article-title":"Prevalence of giant cell arteritis relapse in patients treated with glucocorticoids: a meta-analysis","volume":"725","author":"Maibourg","year":"2020","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.ero.2026.100198_bib0005","first-page":"737","article-title":"Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden","volume":"29","author":"Uddhammar","year":"2002","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ero.2026.100198_bib0006","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/rheumatology\/40.11.1238","article-title":"Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls","volume":"40","author":"Gran","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2026.100198_bib0007","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3899\/jrheum.101254","article-title":"Mortality in patients with biopsy-proven giant cell arteritis: a South Australian population-based study","volume":"38","author":"Ninan","year":"2011","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ero.2026.100198_bib0008","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/acr.24133","article-title":"Incidence trends and mortality of giant cell arteritis in Southern Norway","volume":"73","author":"Andersen","year":"2021","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.ero.2026.100198_bib0009","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/annrheumdis-2013-204652","article-title":"Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden","volume":"74","author":"Mohammad","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ero.2026.100198_bib0010","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/acr.23538","article-title":"Mortality in patients with giant cell arteritis: a cohort study in UK primary care","volume":"70","author":"Li","year":"2018","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.ero.2026.100198_bib0011","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13075-019-1945-4","article-title":"Survival and death causes of patients with giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study","volume":"21","author":"Brekke","year":"2019","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.ero.2026.100198_bib0012","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/rheumatology\/keab507","article-title":"All-cause and cause-specific mortality in patients with giant cell arteritis: a nationwide population-based cohort study","volume":"61","author":"Therkildsen","year":"2022","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ero.2026.100198_bib0013","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/rheumatology\/keu303","article-title":"Mortality in patients with giant cell arteritis","volume":"54","author":"Baslund","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.ero.2026.100198_bib0014","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/acr.22942","article-title":"Incidence, prevalence and survival of biopsy-proven giant cell arteritis in Northern Italy during a 26-year period","volume":"69","author":"Catanose","year":"2017","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.ero.2026.100198_bib0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3899\/jrheum.160797","article-title":"Risk of Diabetes Mellitus among patients diagnosed with giant cell arteritis or granulomatosis with polyangiitis: comparison with the general population","volume":"44","author":"Faurschou","year":"2017","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ero.2026.100198_bib0016","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/rheumatology\/key028","article-title":"Mortality causes and trends associated with giant cell arteritis: analysis of the French national death certificate databse (1980-2011)","volume":"57","author":"Aouba","year":"2018","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ero.2026.100198_bib0017","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Helmich","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ero.2026.100198_bib0018","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol."},{"key":"10.1016\/j.ero.2026.100198_bib0019","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2147\/CLEP.S258219","article-title":"Positive predictive value of the giant cell arteritis diagnosis in the Danish National Patient Registry: a Validation Study","volume":"12","author":"Hjort","year":"2020","journal-title":"Clin Epidemiol."},{"key":"10.1016\/j.ero.2026.100198_bib0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/1403494811404278","article-title":"The National Diabetes Register","volume":"39","author":"Carstensen","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.ero.2026.100198_bib0021","article-title":"Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: a Danish 24-year population-based study","volume":"14","author":"Knudsen","year":"2022","journal-title":"Lancet Reg Health Eur."},{"key":"10.1016\/j.ero.2026.100198_bib0022","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Rao Kondapally Seshasai","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ero.2026.100198_bib0023","article-title":"Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study)","volume":"8","author":"Mahr","year":"2021","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.ero.2026.100198_bib0024","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/rheumatology\/keae107","article-title":"The one-year infection risk among patients diagnosed with giant cell arteritis: use of antibiotics and hospitalisations","volume":"64","author":"Therkildsen","year":"2025","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ero.2026.100198_bib0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/rheumatology\/kev262","article-title":"Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study","volume":"55","author":"Amiri","year":"2016","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ero.2026.100198_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011295","article-title":"Diabetes mellitus\u2013related all-cause and cardiovascular mortality in a National Cohort of Adults","volume":"8","author":"Raghavan","year":"2019","journal-title":"J AM Heart Assoc."},{"key":"10.1016\/j.ero.2026.100198_bib0027","doi-asserted-by":"crossref","first-page":"14","DOI":"10.23937\/2469-5858\/1510014","article-title":"Type 2 diabetes in the elderly: challenges in a unique patient population","volume":"2","author":"Bradley","year":"2016","journal-title":"J Geriatr Med Gerontol."}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126000972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126000972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:32:20Z","timestamp":1790343140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708126000972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3050708126000972"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2026.100198","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of diabetes mellitus on mortality in patients with giant cell arteritis","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2026.100198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}],"article-number":"100198"}}